Skip to main content

Table 4 Predictors of NT-proBNP non-responders

From: N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement

Variables

Adjusted OR

95% CI

P value

Hypertension

1.637

0.922–2.905

0.092

Hyperlipidaemia

1.154

0.661–2.016

0.613

NT-proBNP ≥ 1429.60 at baseline

0.257

0.136–0.487

< 0.001

Peripheral vascular disease

2.537

1.091–5.971

0.031

Chronic heart failure

0.581

0.128–2.643

0.482

Pure aortic insufficiency

0.957

0.277–3.305

0.945

Left ventricular ejection fraction, increase by 1%

1.042

1.010–1.075

0.011

Maximum velocity, increase by 1 m/s

0.576

0.414–0.801

0.001

Mitral regurgitation ≥ moderate

1.114

0.359–3.454

0.851

Tricuspid regurgitation ≥ moderate

0.239

0.052–1.098

0.066

Pulmonary hypertension

0.742

0.350–1.570

0.434

Total length of hospitalization, increase by 1 day

1.031

1.000-1.063

0.053

  1. OR, odds ratio; CI, confidence interval. NT-proBNP, N-terminal pro–B-type natriuretic peptide